Michigan's Medicaid program received approval from CMS to enter into value-based care arrangements with drugmakers, CMS administrator Seema Verma announced during a speech at a biopharma conference Nov. 14. The proposal grants the state's Medicaid program permission to pay for…
Pharmacy
CMS Administrator Seema Verma discussed the Trump administration's drug-pricing initiatives in Medicare during a speech at the Biopharma Congress in Washington, D.C. on Nov. 14.
In a blow for the U.S. drugmaker, Pfizer lost a yearslong patent battle for its blockbuster pain drug Lyrica after the U.K. Supreme Court ruled against it Nov. 14, according to Reuters.
Despite increased anti-overdosing campaigns, a large portion of pharmacies are not up to date with stocking the over-the-counter opioid overdose antidote naloxone, according to STAT.
Drug companies have been using social media influencers to promote products, and for years Boston-based Wego Health has acted as the middleman, bringing pharmaceutical companies and influencers together, according to STAT.
Advertisement
How health systems can overcome barriers to entry to drive better outcomes
AstraZeneca has sold U.S. rights to its treatment for infant lung infections to Swedish Orphan Biovitrum for $1.5 billion, the latest move by the drugmaker to trim its pipeline and refocus on priority drugs, according to Bloomberg.
Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates and rein in the out-of-pocket costs its clients' members…
Nestle's health science arm will pay $98 million to increase its stake in Aimmune Therapeutics, which is preparing to submit an FDA filing for its peanut allergy treatment, Reuters reports.
The American Medical Association adopted a policy at its semiannual meeting Nov. 12 that will allow Americans to purchase medicine from Canada in person to fight escalating prescription drug prices in the U.S.